cdc.gov/coronavirus

ACIP COVID-19 Vaccines Work Group

Dr. Matthew F. Daley, Work Group Chair

February 24, 2023
 December 8, 2022: FDA1 granted emergency use authorization (EUA) for:

–

–

Use of Moderna bivalent COVID-19 vaccine booster in children ages 6 months-5 years 

Use of Pfizer-BioNTech bivalent COVID-19 vaccine as a third primary series dose for 

children 6 months-4 years of age

 December 9, 2022: CDC2 expanded the use of updated (bivalent) COVID-19 

vaccines for children 6 months through 5 years

COVID-19 vaccine update:

Bivalent booster authorizations extended to children ages 6 months and older

2

1. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-updated-bivalent-covid-19-vaccines-children-down-6-months

2. https://www.cdc.gov/media/releases/2022/s1209-covid-vaccine.html
 Epidemiology of COVID-19, including MIS-C and hospitalization data 

 Vaccine effectiveness (VE) updates

 COVID-19 among persons with immunocompromise, including VE and Evusheld updates 

 Discussions for inputs on cost effectiveness analyses 

 COVID-19 vaccine safety updates 

 Review benefit/risk analysis

 Updates to COVID-19 vaccines in children 6 months through 5 years of age, including 

Moderna COVID-19 vaccine booster doses 

 Ongoing work to increase uptake of bivalent COVID-19 vaccines

 Considerations for transition to bivalent primary series

 Future directions for COVID-19 vaccines 

ACIP COVID-19 Work Group Meeting Review

October 2022–February 2023

3
 COVID-19 vaccine safety updates: CDC Dr. Shimabukuro (CDC)

 COVID-19 vaccine safety update: FDA Dr. Forshee (FDA)

 VaST summary Dr. Talbot (ACIP, VaST)

 Work Group interpretation and summary Dr. Twentyman (CDC)

Break

 Updates on COVID-19 hospitalizations in the US Dr. Taylor (CDC)

 Updates to COVID-19 vaccine effectiveness in the US Dr. Britton (CDC)

 Considerations for transitioning to bivalent primary series Dr. Oliver (CDC)

 Work Group interpretation and summary Dr. Twentyman (CDC)

 Discussion

Break

 Benefit-risk analysis for COVID-19 vaccines Dr. Wallace (CDC)

 COVID-19 vaccines: future directions Dr. Oliver (CDC)

 Discussion

Agenda: Friday February 24, 2023
ACIP members

 Matthew Daley (chair)

 Beth Bell 

 Grace Lee

 Keipp Talbot

 Oliver Brooks

Ex-officio/government members

 FDA: Rachel Zhang, Lucia Lee, Anuja Rastogi

 NIH: Chris Roberts

 IHS: Uzo Chukwuma

 CMS: Jeff Kelman

 BARDA: Christine Oshansky

 HHS: David Kim

 CDC: Alan Lam

CDC Leads

 Sara Oliver

 Evelyn Twentyman

Work Group members

5

Liaisons

 AAFP: Jonathan Temte

 AAP: Sean O’Leary

 ACOG: Denise Jamieson (primary), 

Laura Riley (alternate)

 ACP: Jason Goldman

 ADS: Emily Kahn

 AGS: Ken Schmader

 AIM: Rob Shechter (primary), 

Jane Zucker (alternate)

 AMA: Sandra Fryhofer

 ANA: Ruth Francis (alternate)

 APhA: Michael Hogue

 ASTHO: Marcus Plescia

 CSTE: Susan Lett, Paul Cieslak, Christine 

Hahn

IDSA: Jeff Duchin (primary)

Liaisons, cont’d











NACCHO: Matt Zahn (primary), 

Jeff Duchin (alternate)

NACI: Matthew Tunis (primary),

Nicole Forbes (alternate)

NFID: Bill Schaffner (primary), 

Marla Dalton (alternate)

NMA: Patricia Whitley-Williams

SHEA: Marci Drees,

Preeti Mehrotra (alternate) 

Consultants





Ed Belongia

Kathy Kinlaw 

 Dayna Matthew 

 Kathleen Neuzil

 Stanley Perlman 

 Peter Szilagyi

 Hank Bernstein
 Sarah Meyer

 Elisha Hall

 Megan Wallace

 Danielle Moulia

 Lauren Roper

 Hannah Rosenblum

 Katherine Fleming-Dutra

 Monica Godfrey

 Susan Goldstein

 Mary Chamberland

 Stephen Hadler

 JoEllen Wolicki

 Melinda Wharton

 Jessica MacNeil

 Amanda Cohn

CDC participants

6

 Ruth Link-Gelles

 Amadea Britton

 Carolyn Bridges

 Allison Ciesla 

 Nicole Dowling

 Ashley Fowlkes

 Heather Scobie

 Natalie Thornburg

 Tom Shimabukuro

 John Su

 Julianne Gee

 Karen Broder

 Rita Helfand

 Jefferson Jones

 Yvonne Bolen

 Ismael Ortega-Sanchez

 Pragna Patel 

 Amanda Payne

 Georgina Peacock

 Jose Romero

 Laura Steinhardt

 Ryan Wiegand

 Patricia Yu

 Yon Yu

 Samuel Graitcer

 Lisa Grohskopf

 Katherine Grusich

 Aaron Hall

 Ebony Houston

 Terri Hyde

 Cynthia Jorgensen

 Kristen Nordlund

 Sierra Scarbrough

 Edwin Shanley

 Andrew Kroger

 Lauri Markowitz

 Noelle-Angelique Molinari

 Michael McNeil

 Morgan Najdowski
For more information, contact CDC

1-800-CDC-INFO (232-4636)

TTY: 1-888-232-6348 www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the 

official position of the Centers for Disease Control and Prevention.

Thank you!